Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Nucl Med Mol Imaging ; 36(4): 648-52, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19050873

ABSTRACT

PURPOSE: To evaluate the role of FDG-PET/CT scanning in the management of HIV-associated multicentric Castleman's disease (MCD) a rare lymphoproliferative disorder associated with infection by human herpesvirus 8 (HHV8). MATERIALS AND METHODS: Nine patients with histologically confirmed MCD underwent fused FDG-PET/CT scans at initial MCD diagnosis (n = 3), at MCD relapse (n = 4), or during remission (n = 2). All seven patients with active MCD had markedly elevated plasma HHV8 viral loads, but the patients in remission had no HHV8 viraemia. The three patients with newly diagnosed MCD were not on antiretroviral therapy at the time of imaging, but the other six were all on fully suppressive antiretroviral regimens. RESULTS: In the seven patients with active MCD (newly diagnosed or relapse) 33/91 lymph node groups (36%) included radiologically enlarged nodes on the CT scan, whilst 57/91 lymph node groups (63%) showed enhanced FDG uptake on the PET scan. In scans from patients in remission, there were no enlarged lymph nodes on the CT scan but 3 lymph nodes (11%) demonstrated enhanced FDG uptake. The median SUV recorded for the seven patients with active MCD was 4.8 (range 2.6-9.3) which was significantly higher than the median value of 2.5 recorded for the patients in remission (Mann-Whitney U test, p = 0.011). CONCLUSION: Despite the small number of patients, in HIV-positive individuals with active MCD, FDG-PET scans more frequently detected abnormal uptake than CT scans detected enlarged lymph nodes. FDG-PET scanning has a useful role in the management of HIV-associated MCD in selecting appropriate sites for biopsy, and in staging and monitoring these lymphoproliferations.


Subject(s)
Castleman Disease/diagnostic imaging , Castleman Disease/diagnosis , Fluorodeoxyglucose F18/pharmacology , Positron-Emission Tomography/methods , Radiopharmaceuticals/pharmacology , Tomography, X-Ray Computed/methods , Adult , Anti-Retroviral Agents/pharmacology , Female , HIV Infections/diagnosis , HIV Infections/diagnostic imaging , Humans , Lymph Nodes/pathology , Lymphoproliferative Disorders/diagnostic imaging , Male , Middle Aged , Remission Induction
2.
J HIV Ther ; 13(3): 72-4, 2008 Sep.
Article in English | MEDLINE | ID: mdl-19039298

ABSTRACT

Multicentric Castleman[']s disease (MCD) is an uncommon lymphoproliferative disorder that presents with fevers, anaemia and multifocal lymphadenopathy and nowadays is most commonly diagnosed in individuals infected with HIV-1. CT scan findings are not sufficiently reliable to establish a diagnosis of MCD which requires histological confirmation. Newer imaging techniques have therefore been studied in patients with HIV-associated MCD in an attempt to improve diagnostic accuracy. Preliminary findings suggest that FDG PET-CT may assist in the monitoring of disease activity in MCD along with familiar clinical and laboratory tools and the more recently introduced plasma HHV8 DNA viral load measurement.


Subject(s)
HIV-1 , Positron-Emission Tomography , HIV Infections , Herpesvirus 8, Human , Humans , Lymphoproliferative Disorders , Plasma , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...